OTC Healthcare in the United Kingdom
Euromonitor International's OTC Healthcare in the United Kingdom market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 128 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
OTC healthcare market remains stable despite economic slump
The UK economy is seeing tough times as progressive contraction put the country into recession, the pound plunges in value, unemployment rises, industry is hit and consumer spending falls. The UK it set to see some of the most significant falls in living standards of any major economy and continued significant hardship over the course of 2009. However, the OTC healthcare market is managing to prevail despite price pressures from major grocery chains and private label products and significant falls in consumer confidence.
Smokers and elderly continue to bolster market
The 2007 smoking ban, which followed comparable bans in Scotland, Wales and Northern Ireland, and extensive public health campaigns, continues to support strong growth in NRT smoking cessation aids, and potentially further categories. These include products such as weight control, calming and sleeping products and vitamins and dietary supplements, as those giving up smoking turn to numerous other products for help in succeeding and to promote healthier lifestyles. In addition to this, changing demographics in the UK, which is seeing the size of the elderly population increase is helping to support growth in many OTC healthcare categories as these consumers face more health problems with their older age.
Market remains dominated by megabrands
The OTC healthcare market continues to be led by ironclad brands and players such as Reckitt Benckiser, although this is now in a largely stagnant market, following the spate of merger and acquisition activity during the review period. Many of the brands however, are long-time trusted names and people seem less inclined to experiment with products when it comes to their OTC medication leading to little fluctuation in terms of value shares as consumers remain largely loyal to the brands they find most effective or have simply grown accustomed to purchasing them.
Shoppers continue to shift to supermarkets
The retail distribution in the OTC healthcare market was fairly stable in 2008, with consumers continuing to favour grocery retailers and chemists/pharmacies, which represented steady shares: though with grocery retailers having shown an increase from 2003 in terms of their retail distribution share while chemists/pharmacies have seen an overall decline. Supermarkets and comparable grocery channels have seen this movement as the number in in-store pharmacies increases and consumer confidence grows in private label products in the face of dismal economic conditions, while consumers also continue to prefer one-stop shopping options for all their needs.
Recession expected to bypass OTC healthcare market
Growth of the OTC healthcare market is anticipated to remain good over the forecast period despite expected further falls in UK GDP and sluggish consumer retail markets. Price pressure is expected to remain a feature of the market as the top grocery chains expand their OTC ranges and private label offerings. Value growth will be supported by growing demand from an ageing consumer base, new product development and further medication reclassifications to OTC status.
Table of contents
OTC HEALTHCARE IN THE UNITED KINGDOM : MARKET INSIGHT
EXECUTIVE SUMMARY
OTC healthcare market remains stable despite economic slump
Smokers and elderly continue to bolster market
Market remains dominated by megabrands
Shoppers continue to shift to supermarkets
Recession expected to bypass OTC healthcare market
KEY TRENDS AND DEVELOPMENTS
John Bull faces bear market
Fat is the new thin
Consumers cherish their chains
National Stealth Service
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
DEFINITIONS
Sources
Summary 2 Research Sources
LOCAL COMPANY PROFILES - UNITED KINGDOM
BAYER PLC - OTC HEALTHCARE - UNITED KINGDOM
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Bayer Plc: Key Facts
Summary 4 Bayer Plc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 Bayer Plc: Competitive Position 2008
GLAXOSMITHKLINE PLC - OTC HEALTHCARE - UNITED KINGDOM
STRATEGIC DIRECTION
KEY FACTS
Summary 6 GlaxoSmithKline Plc: Key Facts
Summary 7 GlaxoSmithKline Plc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 GlaxoSmithKline: Competitive Position 2008
RECKITT BENCKISER PLC - OTC HEALTHCARE - UNITED KINGDOM
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Reckitt Benckiser Plc: Key Facts
Summary 10 Reckitt Benckiser Plc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 11 Reckitt Benckiser Plc: Competitive Position 2008
ANALGESICS IN THE UNITED KINGDOM
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 16 Analgesics Company Shares by Value 2004-2008
Table 17 Analgesics Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE UNITED KINGDOM
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 22 Sales of Decongestants by Type: Value 2003-2008
Table 23 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 26 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN THE UNITED KINGDOM
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 31 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 32 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 33 Herbal vs Standard Digestive Remedies 2003-2008
Table 34 Digestive Remedies Company Shares by Value 2004-2008
Table 35 Digestive Remedies Brand Shares by Value 2005-2008
Table 36 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN THE UNITED KINGDOM
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 38 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 39 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 40 Herbal vs Standard Medicated Skin Care 2003-2008
Table 41 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 42 Medicated Skin Care Company Shares by Value 2004-2008
Table 43 Medicated Skin Care Brand Shares by Value 2005-2008
Table 44 Acne Treatments Brand Shares by Value 2005-2008
Table 45 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 46 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 47 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN THE UNITED KINGDOM
HEADLINES
TRENDS
Vitamins
Dietary Supplements
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Summary 12 Dietary Supplements: Brand Ranking by Positioning 2008 Low Calorie Carbonates by Subsector
SECTOR DATA
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 50 Folic Acid v Other B Vitamins 2004-2008
Table 51 Dietary Supplements by Positioning 2006-2008
Table 52 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 53 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 54 Vitamins Brand Shares by Value 2005-2008
Table 55 Dietary Supplements Brand Shares by Value 2005-2008
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN THE UNITED KINGDOM
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 58 Number of Smokers by Gender 2003-2008
Table 59 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 60 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 61 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 62 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 63 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN THE UNITED KINGDOM
HEADLINES
SECTOR DATA
Table 66 Sales of Eye Care by Subsector: Value 2003-2008
Table 67 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 68 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 69 Eye Care Company Shares by Value 2004-2008
Table 70 Eye Care Brand Shares by Value 2005-2008
Table 71 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 72 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN THE UNITED KINGDOM
HEADLINES
SECTOR DATA
Table 73 Sales of Ear Care: Value 2003-2008
Table 74 Sales of Ear Care: % Value Growth 2003-2008
Table 75 Ear Care Company Shares by Value 2004-2008
Table 76 Ear Care Brand Shares by Value 2005-2008
Table 77 Forecast Sales of Ear Care: Value 2008-2013
Table 78 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN THE UNITED KINGDOM
HEADLINES
SECTOR DATA
Table 79 Sales of Adult Mouth Care: Value 2003-2008
Table 80 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 81 Adult Mouth Care Company Shares by Value 2004-2008
Table 82 Adult Mouth Care Brand Shares by Value 2005-2008
Table 83 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 84 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN THE UNITED KINGDOM
HEADLINES
SECTOR DATA
Table 85 Sales of Calming and Sleeping Products: Value 2003-2008
Table 86 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 87 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 88 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 89 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 90 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN THE UNITED KINGDOM
HEADLINES
SECTOR DATA
Table 91 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 92 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 93 Wound Treatments Company Shares by Value 2004-2008
Table 94 Wound Treatments Brand Shares by Value 2005-2008
Table 95 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 96 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
OTC OBESITY IN THE UNITED KINGDOM
HEADLINES
SECTOR DATA
Table 97 Forecast Sales of OTC Obesity: Value 2009-2013
Table 98 Forecast Sales of OTC Obesity: % Value Growth 2009-2013
EMERGENCY CONTRACEPTION IN THE UNITED KINGDOM
HEADLINES
SECTOR DATA
Table 99 Sales of Emergency Contraception: Value 2003-2008
Table 100 Sales of Emergency Contraception: % Value Growth 2003-2008
Table 101 Emergency Contraception Company Shares by Value 2004-2008
Table 102 Emergency Contraception Brand Shares by Value 2005-2008
Table 103 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 104 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013
OTC STATINS IN THE UNITED KINGDOM
HEADLINES
SECTOR DATA
Table 105 Sales of OTC Statins: Value 2004-2008
Table 106 Sales of OTC Statins: % Value Growth 2004-2008
Table 107 OTC Statins Company Shares by Value 2004-2008
Table 108 OTC Statins Brand Shares by Value 2005-2008
Table 109 Forecast Sales of OTC Statins: Value 2008-2013
Table 110 Forecast Sales of OTC Statins: % Value Growth 2008-2013
OTC TRIPTANS IN THE UNITED KINGDOM
HEADLINES
SECTOR DATA
Table 111 Sales of OTC Triptans: Value 2006-2008
Table 112 Sales of OTC Triptans: % Value Growth 2006-2008
Table 113 OTC Triptans Company Shares by Value 2006-2008
Table 114 OTC Triptans Brand Shares by Value 2006-2008
Table 115 Forecast Sales of OTC Triptans: Value 2008-2013
Table 116 Forecast Sales of OTC Triptans: % Value Growth 2008-2013